Australia's most trusted
source of pharma news
Thursday, 20 March 2025
Posted 19 March 2025 PM
After two years in the cold following a dramatic suspension from the UK industry body for serious Code breaches, Novo Nordisk has been welcomed back to the Association of the British Pharmaceutical Industry (ABPI).
The company's return to full membership this week follows extensive audits of its compliance procedures and governance by the ABPI's investigative arm the Prescription Medicines Code of Practice Authority.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.